Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: per strandberg who wrote (2625)	11/5/1997 11:00:00 AM
From: tommysdad	Read Replies (2) of 6136

If you don't mind a response from a proud, card-carrying member of the Little Punk Patrol -- A search of a few of my favorite databases revealed no recent news about AG3340. Results of a Phase I study were reported in April: agouron.com Steven Bender, a chemist on the MMP project, gave a nice talk describing the discovery of AG3340 at the American Chemical Society meeting in Las Vegas in September which was very positive, but there was no new quantitative biological data presented ("initial studies have been encouraging"). I believe the abstract you posted is the most recent info on efficacy of AG3340 in any species.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next